These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16594594)

  • 21. Rectal lymphoma in 11 dogs: a retrospective study.
    Van den Steen N; Berlato D; Polton G; Dobson J; Stewart J; Maglennon G; Hayes AM; Murphy S
    J Small Anim Pract; 2012 Oct; 53(10):586-91. PubMed ID: 22882127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
    Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
    J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escalating dose of mitoxantrone with high-dose cyclophosphamide, carmustine, and etoposide in patients with refractory lymphoma undergoing autologous bone marrow transplantation.
    Attal M; Canal P; Schlaifer D; Chatelut E; Dezeuze A; Huguet F; Payen C; Pris J; Laurent G
    J Clin Oncol; 1994 Jan; 12(1):141-8. PubMed ID: 8270970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma?
    Hahn KA; Richardson RC; Teclaw RF; Cline JM; Carlton WW; DeNicola DB; Bonney PL
    J Vet Intern Med; 1992; 6(1):3-10. PubMed ID: 1548624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoma: which chemotherapy protocol and why?
    Chun R
    Top Companion Anim Med; 2009 Aug; 24(3):157-62. PubMed ID: 19732735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome and toxicity associated with a dose-intensified, maintenance-free CHOP-based chemotherapy protocol in canine lymphoma: 130 cases.
    Sorenmo K; Overley B; Krick E; Ferrara T; LaBlanc A; Shofer F
    Vet Comp Oncol; 2010 Sep; 8(3):196-208. PubMed ID: 20691027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
    Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
    Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marrow transplant studies in dogs with malignant lymphoma.
    Appelbaum FR; Deeg HJ; Storb R; Self S; Graham TC; Sale GE; Weiden PL
    Transplantation; 1985 May; 39(5):499-504. PubMed ID: 3887690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.
    Siedlecki CT; Kass PH; Jakubiak MJ; Dank G; Lyons J; Kent MS
    Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
    Wang SL; Lee JJ; Liao AT
    Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of CCNU and DTIC chemotherapy for treatment of resistant lymphoma in dogs.
    Flory AB; Rassnick KM; Al-Sarraf R; Bailey DB; Balkman CE; Kiselow MA; Autio K
    J Vet Intern Med; 2008; 22(1):164-71. PubMed ID: 18289305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.
    Burton JH; Garrett-Mayer E; Thamm DH
    Vet Comp Oncol; 2013 Dec; 11(4):306-15. PubMed ID: 22548975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechlorethamine, procarbazine and prednisone for the treatment of resistant lymphoma in dogs.
    Northrup NC; Gieger TL; Kosarek CE; Saba CF; LeRoy BE; Wall TM; Hume KR; Childress MO; Keys DA
    Vet Comp Oncol; 2009 Mar; 7(1):38-44. PubMed ID: 19222829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?
    Marconato L; Bonfanti U; Stefanello D; Lorenzo MR; Romanelli G; Comazzi S; Zini E
    Vet Comp Oncol; 2008 Jun; 6(2):80-9. PubMed ID: 19178667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study.
    Humblet Y; Symann M; Bosly A; Delaunois L; Francis C; Machiels J; Beauduin M; Doyen C; Weynants P; Longueville J
    J Clin Oncol; 1987 Dec; 5(12):1864-73. PubMed ID: 2824708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
    Goodman IH; Moore AS; Frimberger AE
    Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of relapsed canine lymphoma with doxorubicin and dacarbazine.
    Van Vechten M; Helfand SC; Jeglum KA
    J Vet Intern Med; 1990; 4(4):187-91. PubMed ID: 2401965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of canine lymphoma with COPLA/LVP.
    Boyce KL; Kitchell BE
    J Am Anim Hosp Assoc; 2000; 36(5):395-403. PubMed ID: 10997514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma.
    Price GS; Page RL; Fischer BM; Levine JF; Gerig TM
    J Vet Intern Med; 1991; 5(5):259-62. PubMed ID: 1748977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.